Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to 0.4.

  • Cytek Biosciences' Asset Utilization Ratio fell 349.32% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year decrease of 349.32%. This contributed to the annual value of 0.4 for FY2024, which is 594.08% up from last year.
  • Latest data reveals that Cytek Biosciences reported Asset Utilization Ratio of 0.4 as of Q3 2025, which was down 349.32% from 0.4 recorded in Q2 2025.
  • Cytek Biosciences' Asset Utilization Ratio's 5-year high stood at 0.41 during Q3 2024, with a 5-year trough of 0.28 in Q4 2021.
  • Over the past 5 years, Cytek Biosciences' median Asset Utilization Ratio value was 0.35 (recorded in 2023), while the average stood at 0.36.
  • Per our database at Business Quant, Cytek Biosciences' Asset Utilization Ratio crashed by 1086.16% in 2022 and then surged by 2796.24% in 2024.
  • Quarter analysis of 5 years shows Cytek Biosciences' Asset Utilization Ratio stood at 0.28 in 2021, then increased by 15.47% to 0.32 in 2022, then grew by 18.23% to 0.38 in 2023, then rose by 6.28% to 0.4 in 2024, then decreased by 1.56% to 0.4 in 2025.
  • Its Asset Utilization Ratio stands at 0.4 for Q3 2025, versus 0.4 for Q2 2025 and 0.4 for Q1 2025.